Example 35.8 Cochran-Armitage Trend Test

The data set Pain contains hypothetical data for a clinical trial of a drug therapy to control pain. The clinical trial investigates whether adverse responses increase with larger drug doses. Subjects receive either a placebo or one of four drug doses. An adverse response is recorded as Adverse='Yes'; otherwise, it is recorded as Adverse='No'. The number of subjects for each drug dose and response combination is contained in the variable Count.

   data pain;
      input Dose Adverse $ Count @@;
      datalines;
   0 No 26   0 Yes  6
   1 No 26   1 Yes  7
   2 No 23   2 Yes  9
   3 No 18   3 Yes 14
   4 No  9   4 Yes 23
   ;

The following PROC FREQ statements provide a trend analysis. The TABLES statement requests a table of Adverse by Dose. The MEASURES option produces measures of association, and the CL option produces confidence limits for these measures. The TREND option tests for a trend across the ordinal values of the variable Dose with the Cochran-Armitage test. The EXACT statement produces exact -values for this test, and the MAXTIME= option terminates the exact computations if they do not complete within 60 seconds. The TEST statement computes an asymptotic test for Somers’ .

The PLOTS= option requests a frequency plot for the table of Adverse by Dose. By default, PROC FREQ provides a bar chart for the frequency plot. The TWOWAY=STACKED option requests a stacked layout, where the bars correspond to the column variable (Dose) values, and the row variable (Adverse) frequencies are stacked within each bar.

   ods graphics on;
   proc freq data=Pain;
      tables Adverse*Dose / trend measures cl
             plots=freqplot(twoway=stacked);
      test smdrc;
      exact trend / maxtime=60;
      weight Count;
      title 'Clinical Trial for Treatment of Pain';
   run;
   ods graphics off;

Output 35.8.1 through Output 35.8.4 display the results of the analysis. The "Col Pct" values in Output 35.8.1 show the expected increasing trend in the proportion of adverse effects with the increasing dosage (from 18.75% to 71.88%). The corresponding frequency bar chart (Output 35.8.2) also shows this increasing trend.